- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Dynamic equinus foot deformity; Moderate to severe spasticity of the upper limb
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
IncobotulinumtoxinA – July 2025
IncobotulinumtoxinA; Lyophilised powder for injection 100 units; Xeomin®
Last updated
9 July 2025